|
Roche, FDA announce new drug-interaction warnings for mibefradil. |
1998 |
Am J Health Syst Pharm |
pmid:9492249
|
Ku YM et al. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. |
1995 |
Am J Health Syst Pharm |
pmid:8528874
|
Greanya ED et al. |
Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen. |
2012 |
Am J Health Syst Pharm |
pmid:22215359
|
Heavner MS et al. |
Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. |
2013 |
Am J Health Syst Pharm |
pmid:23943182
|
Curtin BF et al. |
Unusually late-onset mycophenolate mofetil-related colitis. |
2014 |
Am J Health Syst Pharm |
pmid:25320135
|
Bonhomme-Faivre L et al. |
Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients. |
2009 |
Am J Health Syst Pharm |
pmid:19729569
|
Lee JH et al. |
Stability of tacrolimus solutions in polyolefin containers. |
2016 |
Am J Health Syst Pharm |
pmid:26796907
|
|
Tacrolimus. |
2001 |
Am J Health Syst Pharm |
pmid:11794952
|
Lee B et al. |
Appropriate timing of tacrolimus concentration measurements in the emergency department. |
2016 |
Am J Health Syst Pharm |
pmid:27543574
|
Jacobson PA et al. |
Stability of tacrolimus in an extemporaneously compounded oral liquid. |
1997 |
Am J Health Syst Pharm |
pmid:9117806
|
Utecht KN et al. |
Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors. |
2006 |
Am J Health Syst Pharm |
pmid:17106006
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
MacDonald AS and Sketris IS |
Tacrolimus in transplantation. |
1995 |
Am J Health Syst Pharm |
pmid:7552906
|
Johnson CE et al. |
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration. |
1999 |
Am J Health Syst Pharm |
pmid:10030533
|
Pennington CA and Park JM |
Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. |
2015 |
Am J Health Syst Pharm |
pmid:25631834
|
Tsapepas DS et al. |
Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient. |
2011 |
Am J Health Syst Pharm |
pmid:21200061
|
Myers AL et al. |
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags. |
2016 |
Am J Health Syst Pharm |
pmid:27919876
|
Grouzmann E et al. |
Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration. |
2008 |
Am J Health Syst Pharm |
pmid:18216007
|
Taormina D et al. |
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. |
1992 |
Am J Hosp Pharm |
pmid:1373936
|
|
Tacrolimus introduced for use in liver transplantation. |
1994 |
Am J Hosp Pharm |
pmid:7524317
|